NYSE:KSS

Bath & Body Works Rises 3.6% as Q2 Beats Guidance and Turnaround Shows Early Progress

Bath & Body Works (NYSE: BBWI) shares rose about 3.6% after the retailer reported fiscal second-quarter 2026 sales and earnings above its guidance and raised its full-year earnings outlook. The positive reaction comes despite continued sales pressure, suggesting investors are focusing on early signs that the company's turnaround strategy is beginning to gain traction.

Q2 Results Beat Expectations

Second-quarter net sales were $1.51 billion, down 2.3% year over year. While revenue remained under pressure, management said the result exceeded its guidance.

Adjusted EPS reached $0.62, compared with $0.37 a year earlier, while adjusted operating income increased to $225 million from $172 million.

However, the headline earnings improvement was heavily influenced by approximately $80 million of tariff refunds. Excluding that benefit, adjusted EPS would have been $0.31.

That distinction is important: the quarter was better than management expected, but the reported year-over-year earnings growth substantially overstates the improvement in the underlying business.

Turnaround Signals Support the Stock

The more encouraging development may be operational rather than purely financial.

Bath & Body Works reported its first quarter of direct net sales growth since 2021, which management attributed partly to improvements in its digital shopping experience. The company also cited sequential improvement in Body Care, stronger average unit retail on new product innovation and continued momentum through marketplace partnerships.

CEO Daniel Heaf said these developments provide early evidence that the company's "Consumer First Formula" strategy is working, although he acknowledged that underlying business trends remain pressured.

For investors, evidence that digital sales and key product categories are stabilizing could be particularly important after an extended period of weak growth.

Full-Year EPS Guidance Raised, But Sales Still Expected to Fall

Bath & Body Works raised fiscal 2026 GAAP EPS guidance to $3.13-$3.33 and adjusted EPS guidance to $2.60-$2.80. The company also expects approximately $650 million of free cash flow.

Sales guidance was narrowed to a decline of 2.5%-4%, indicating that management still expects revenue contraction for the year.

The near-term outlook also remains challenging. For Q3, sales are expected to decline 2.5%-5%, while adjusted EPS of $0.07-$0.12 would be substantially below $0.35 in the year-ago quarter.

The 3.6% rise in BBWI therefore appears to reflect a cautiously positive reaction rather than a clear return to growth. Q2 exceeded guidance, digital sales improved and management raised its earnings outlook, providing evidence that the transformation is making progress. Still, declining sales, weak Q3 earnings guidance and the large contribution from tariff refunds show that the underlying recovery remains at an early stage.
Kohl’s Corporation announced a leadership change effective immediately, appointing Michael Bender as Interim CEO following the termination of former CEO Ashley Buchanan for cause.

The decision came after an investigation found Buchanan had directed vendor transactions involving undisclosed conflicts of interest. His termination is not related to company performance or financial reporting.

Bender, a board member since 2019 and recently appointed Board Chair, brings experience from past executive roles at Eyemart Express, Walmart, L Brands, and PepsiCo. He will step down from his role as Board Chair while serving as Interim CEO. The Board will conduct a formal search for a permanent CEO.

Kohl’s also provided preliminary Q1 2025 financial expectations:
- Comparable sales: down 4.3% to 4.0%
- Operating income: $40 to $45 million
- Diluted EPS: a loss of $0.24 to $0.20

The company will report full Q1 2025 results on May 29, 2025.
Video Thumbnail
08-26-26The Investor
Video Thumbnail
07-23-25WS Investor
Video Thumbnail
05-06-25WS News
Video Thumbnail
05-01-25Global Finance News